Latest Advances

  • Condition: Malignant Mixed Mullerian Tumors of Endometrial Origin
  • Journal: Journal of cancer research and clinical oncology
  • Treatment Used: Platinum/anthracycline Versus Ifosfamide Versus Platinum/taxanes Regimen
  • Number of Patients: 120
  • Published —
In this study, researchers compared the effectiveness of platinum/anthracycline versus ifosfamide versus platinum/taxanes regimen for the treatment of malignant mixed Mullerian tumors of endometrial origin.
  • Condition: Advanced Endometrial Cancer
  • Journal: Cancer chemotherapy and pharmacology
  • Treatment Used: Neoadjuvant Chemotherapy
  • Number of Patients: 39
  • Published —
This study tested the safety and efficacy of using neoadjuvant chemotherapy to treat patients with advanced endometrial cancer.
  • Condition: Advanced-Stage Ovarian Non-High Grade Serous Carcinoma (non-HGSC) in Korean women
  • Journal: BMC cancer
  • Treatment Used: Neoadjuvant Chemotherapy (NAC)
  • Number of Patients: 154
  • Published —
This study evaluated survival rates of Korean women with advanced-stage ovarian non-high grade serous carcinoma (non-HGSC) treated with neoadjuvant chemotherapy (NAC).
  • Condition: Previously Treated Solid Tumors
  • Journal: Investigational new drugs
  • Treatment Used: Navicixizumab
  • Number of Patients: 66
  • Published —
In this study, researchers evaluated the safety and effectiveness of navicixizumab for the treatment of previously treated solid tumors.
  • Condition: Ovarian Carcinosarcoma
  • Journal: BMC cancer
  • Treatment Used: first-line chemotherapy regimens
  • Number of Patients: 31
  • Published —
The purpose of the study was to determine the progression-free survival and overall survival for patients with ovarian carcinosarcoma treated with different first-line chemotherapy regimens.
Showing 1-6 of 6